Zobrazeno 1 - 10
of 140
pro vyhledávání: '"Jay B. Wish"'
Publikováno v:
Kidney Medicine, Vol 6, Iss 9, Pp 100871- (2024)
This review describes the history of vascular access for hemodialysis (HD) over the past 8 decades. Reliable, repeatable vascular access for outpatient HD began in the 1960s with the Quinton-Scribner shunt. This was followed by the autologous Brecia-
Externí odkaz:
https://doaj.org/article/024290cfd824467fad40e3e65cc242c1
Autor:
Hanna Webb, MD, MPH, Jay B. Wish, MD
Publikováno v:
Kidney Medicine, Vol 6, Iss 3, Pp 100795- (2024)
Externí odkaz:
https://doaj.org/article/3429cc72f7f148709952c88b16ab251a
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 6, Iss 6, Pp 536-551 (2022)
Chronic kidney disease (CKD) is one of the most frequent complications associated with type 2 diabetes mellitus (T2DM) and is also an independent risk factor for cardiovascular disease. The mineralocorticoid receptor (MR) is a nuclear receptor expres
Externí odkaz:
https://doaj.org/article/d1b8890195314a4099287ad4f78e73c0
Publikováno v:
Frontiers in Physiology, Vol 13 (2022)
The literature on the relationship between kidney and cardiovascular diseases is continuously expanding. Scientists have elucidated many of the neurohormonal and hemodynamic pathways involved in cardiorenal disease. However, little is known about kid
Externí odkaz:
https://doaj.org/article/39a4f523818d4f0eb26accb2171b3104
Autor:
Steven N. Michalopoulos, Marjolaine Gauthier-Loiselle, Myrlene Sanon Aigbogun, Elizabeth Serra, Rebecca Bungay, Diana Clynes, Martin Cloutier, Erin Kahle, Annie Guérin, Youssef M.K. Farag, Jay B. Wish
Publikováno v:
Kidney Medicine, Vol 4, Iss 4, Pp 100439- (2022)
Rationale & Objective: Chronic kidney disease (CKD) has a far-reaching impact on both patients and care partners, which can be further compounded by frequent complications such as anemia. This study assessed the burden experienced by patients with CK
Externí odkaz:
https://doaj.org/article/99410c57ffd84e34a73e880fd4d48149
Autor:
Jay B. Wish
Publikováno v:
Kidney Medicine, Vol 2, Iss 5, Pp 526-528 (2020)
Externí odkaz:
https://doaj.org/article/cb6c1a608dda49dbbc0d3c355dfd675f
Autor:
Jay B. Wish, Marcelo G. Rocha, Nancy E. Martin, Christian Russel D. Reyes, Steven Fishbane, Mark T. Smith, George Nassar
Publikováno v:
Kidney Medicine, Vol 1, Iss 5, Pp 271-280 (2019)
Rationale & Objective: Epoetin alfa-epbx is a biosimilar to the reference product, epoetin alfa. We compare the safety of epoetin alfa-epbx versus epoetin alfa based on a pooled analysis of findings from 2 randomized, double-blind, comparative clinic
Externí odkaz:
https://doaj.org/article/70749e3d84df4eb6b74e165829bc5d05
Autor:
Elaine Ku, Lucia Del Vecchio, Kai-Uwe Eckardt, Volker H. Haase, Kirsten L. Johansen, Masaomi Nangaku, Navdeep Tangri, Sushrut S. Waikar, Andrzej Więcek, Michael Cheung, Michel Jadoul, Wolfgang C. Winkelmayer, David C. Wheeler, Baris Afsar, Tadao Akizawa, Stefan D. Anker, Mustafa Arici, Jodie L. Babitt, Jonathan Barratt, Jeffrey S. Berns, Anatole Besarab, Sunil Bhandari, Christopher Brown, Aleix Cases, Glenn M. Chertow, Cynthia Delgado, Tillman B. Drüeke, Steven Fishbane, Rafael Gómez, Morgan E. Grams, Takayuki Hamano, Chuan-Ming Hao, Raymond K. Hsu, Kunitoshi Iseki, Isabelle Jordans, Edgar V. Lerma, Francesco Locatelli, Iain C. Macdougall, Jolanta Małyszko, Patrick Maxwell, Lawrence P. McMahon, Gregorio T. Obrador, Marlies Ostermann, Roberto Pecoits-Filho, Farzana Perwad, Simon D. Roger, Ajay K. Singh, Laura Solá, Bruce S. Spinowitz Mai Sugahara, Toshiyuki Takahashi, Mototsugu Tanaka, Tetsuhiro Tanaka, Der-Cherng Tarng, Marcello Tonelli, Yusuke Tsukamoto, Carl P. Walther, Angela Yee-Moon Wang, Bradley A. Warady, Angela C. Webster, Matthew R. Weir, Jay B. Wish, Muh Geot Wong
Publikováno v:
Kidney International.
Autor:
Hanna Webb, Jay B. Wish
Publikováno v:
American Journal of Kidney Diseases.
Autor:
Simit M. Doshi, Jay B. Wish
Publikováno v:
Kidney International Reports. 7:688-698
Cardiovascular (CV) disease (CVD) accounts for50% of deaths with known causes in patients on dialysis. Elevated serum phosphorus levels are an important nontraditional risk factor for bone mineral disease and CVD in patients with chronic kidney disea